
The paper deals with the automatization of therapy for diabetes, one of the metabolic diseases, which is based on medical engineering complexes to provide an accurate correction of abrupt-onset highly progressive pathological processes and to ensure the maximum physiological adequacy of therapy. The paper also gives results of numerous investigations of medical engineering complexes for automatic insulin therapy and reveals the tends and problems concerned with their development.

